{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:47:19Z","timestamp":1790952439503,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s11010-019-03681-x","type":"journal-article","created":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T14:02:21Z","timestamp":1577887341000},"page":"17-24","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["LncRNA MEG3 inhibits the inflammatory response of ankylosing spondylitis by targeting miR-146a"],"prefix":"10.1007","volume":"466","author":[{"given":"Yehong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cunxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3152-0485","authenticated-orcid":false,"given":"Meihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,1]]},"reference":[{"key":"3681_CR1","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","volume":"369","author":"J Braun","year":"2007","unstructured":"Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369:1379\u20131390. https:\/\/doi.org\/10.1016\/S0140-6736(07)60635-7","journal-title":"Lancet"},{"key":"3681_CR2","first-page":"S80","volume":"26","author":"J Zochling","year":"2008","unstructured":"Zochling J, Braun J (2008) Mortality in ankylosing spondylitis. Clin Exp Rheumatol 26:S80\u2013S84","journal-title":"Clin Exp Rheumatol"},{"key":"3681_CR3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/art.23260","volume":"58","author":"J Sieper","year":"2008","unstructured":"Sieper J, Appel H, Braun J, Rudwaleit M (2008) Critical appraisal of assessment of structural damage in ankylosing spondylitis: implications for treatment outcomes. Arthritis Rheum 58:649\u2013656. https:\/\/doi.org\/10.1002\/art.23260","journal-title":"Arthritis Rheum"},{"key":"3681_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jaut.2014.01.015","volume":"48\u201349","author":"SP Raychaudhuri","year":"2014","unstructured":"Raychaudhuri SP, Deodhar A (2014) The classification and diagnostic criteria of ankylosing spondylitis. J Autoimmun 48\u201349:128\u2013133. https:\/\/doi.org\/10.1016\/j.jaut.2014.01.015","journal-title":"J Autoimmun"},{"key":"3681_CR5","first-page":"560","volume":"28","author":"PD Sampaio-Barros","year":"2001","unstructured":"Sampaio-Barros PD, Bertolo MB, Kraemer MH, Neto JF, Samara AM (2001) Primary ankylosing spondylitis: patterns of disease in a Brazilian population of 147 patients. J Rheumatol 28:560\u2013565","journal-title":"J Rheumatol"},{"key":"3681_CR6","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1136\/ard.2011.151191","volume":"70","author":"G Bakland","year":"2011","unstructured":"Bakland G, Gran JT, Nossent JC (2011) Increased mortality in ankylosing spondylitis is related to disease activity. Ann Rheum Dis 70:1921\u20131925. https:\/\/doi.org\/10.1136\/ard.2011.151191","journal-title":"Ann Rheum Dis"},{"key":"3681_CR7","doi-asserted-by":"publisher","first-page":"877","DOI":"10.2217\/epi.15.55","volume":"7","author":"S Lalevee","year":"2015","unstructured":"Lalevee S, Feil R (2015) Long noncoding RNAs in human disease: emerging mechanisms and therapeutic strategies. Epigenomics 7:877\u2013879. https:\/\/doi.org\/10.2217\/epi.15.55","journal-title":"Epigenomics"},{"key":"3681_CR8","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1042\/BST20160376","volume":"45","author":"ZH Kwok","year":"2017","unstructured":"Kwok ZH, Tay Y (2017) Long noncoding RNAs: lincs between human health and disease. Biochem Soc Trans 45:805\u2013812. https:\/\/doi.org\/10.1042\/BST20160376","journal-title":"Biochem Soc Trans"},{"key":"3681_CR9","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature12986","volume":"505","author":"Y Tay","year":"2014","unstructured":"Tay Y, Rinn J, Pandolfi PP (2014) The multilayered complexity of ceRNA crosstalk and competition. Nature 505:344\u2013352. https:\/\/doi.org\/10.1038\/nature12986","journal-title":"Nature"},{"key":"3681_CR10","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3899\/jrheum.151181","volume":"43","author":"Z Xie","year":"2016","unstructured":"Xie Z, Li J, Wang P, Li Y, Wu X, Wang S, Su H, Deng W, Liu Z, Cen S, Ouyang Y, Wu Y, Shen H (2016) Differential expression profiles of long noncoding RNA and mRNA of osteogenically differentiated mesenchymal stem cells in ankylosing spondylitis. J Rheumatol 43:1523\u20131531. https:\/\/doi.org\/10.3899\/jrheum.151181","journal-title":"J Rheumatol"},{"key":"3681_CR11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature12986","volume":"505","author":"X Li","year":"2014","unstructured":"Li X, Chai W, Zhang G, Ni M, Chen J, Dong J, Zhou Y, Hao L, Bai Y, Wang Y (2017) Down-regulation of lncRNA-AK001085 and its influences on the diagnosis of ankylosing spondylitis. Med Sci Monit 23:11\u201316. https:\/\/doi.org\/10.12659\/msm.898915","journal-title":"Nature"},{"key":"3681_CR12","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12891-019-2647-4","volume":"20","author":"H Zhong","year":"2019","unstructured":"Zhong H, Zhong M (2019) LINC00311 is overexpressed in ankylosing spondylitis and predict treatment outcomes and recurrence. BMC Musculoskelet Disord 20:278. https:\/\/doi.org\/10.1186\/s12891-019-2647-4","journal-title":"BMC Musculoskelet Disord"},{"key":"3681_CR13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.5582\/bst.2018.01117","volume":"12","author":"X Lan","year":"2018","unstructured":"Lan X, Ma H, Zhang Z, Ye D, Min J, Cai F, Luo J (2018) Downregulation of lncRNA TUG1 is involved in ankylosing spondylitis and is related to disease activity and course of treatment. Biosci Trends 12:389\u2013394. https:\/\/doi.org\/10.5582\/bst.2018.01117","journal-title":"Biosci Trends"},{"key":"3681_CR14","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1158\/0008-5472.CAN-09-3885","volume":"70","author":"X Zhang","year":"2010","unstructured":"Zhang X, Gejman R, Mahta A, Zhong Y, Rice KA, Zhou Y, Cheunsuchon P, Louis DN, Klibanski A (2010) Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res 70:2350\u20132358. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-3885","journal-title":"Cancer Res"},{"key":"3681_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-012-1038-6","volume":"112","author":"V Balik","year":"2013","unstructured":"Balik V, Srovnal J, Sulla I, Kalita O, Foltanova T, Vaverka M, Hrabalek L, Hajduch M (2013) MEG3: a novel long noncoding potentially tumour-suppressing RNA in meningiomas. J Neurooncol 112:1\u20138. https:\/\/doi.org\/10.1007\/s11060-012-1038-6","journal-title":"J Neurooncol"},{"key":"3681_CR16","doi-asserted-by":"publisher","first-page":"109129","DOI":"10.1016\/j.biopha.2019.109129","volume":"118","author":"S Ghafouri-Fard","year":"2019","unstructured":"Ghafouri-Fard S, Taheri M (2019) Maternally expressed gene 3 (MEG3): A tumor suppressor long non coding RNA. Biomed Pharmacother 118:109129. https:\/\/doi.org\/10.1016\/j.biopha.2019.109129","journal-title":"Biomed Pharmacother"},{"key":"3681_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152558","author":"D Wang","year":"2019","unstructured":"Wang D, Fu CW, Fan DQ (2019) Participation of tumor suppressors long non-coding RNA MEG3, microRNA-377 and PTEN in glioma cell invasion and migration. Pathol Res Pract. https:\/\/doi.org\/10.1016\/j.prp.2019.152558","journal-title":"Pathol Res Pract"},{"key":"3681_CR18","first-page":"3600","volume":"11","author":"M Wang","year":"2019","unstructured":"Wang M, Li C, Zhang Y, Zhou X, Liu Y, Lu C (2019) LncRNA MEG3-derived miR-361-5p regulate vascular smooth muscle cells proliferation and apoptosis by targeting ABCA1. Am J Transl Res 11:3600\u20133609","journal-title":"Am J Transl Res"},{"key":"3681_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14549","author":"X Zhang","year":"2019","unstructured":"Zhang X, Wu N, Wang J, Li Z (2019) LncRNA MEG3 inhibits cell proliferation and induces apoptosis in laryngeal cancer via miR-23a\/APAF-1 axis. J Cell Mol Med. https:\/\/doi.org\/10.1111\/jcmm.14549","journal-title":"J Cell Mol Med"},{"key":"3681_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3892\/etm.2018.6921","volume":"17","author":"W Liu","year":"2019","unstructured":"Liu W, Huang L, Zhang C, Liu Z (2019) lncRNA MEG3 is downregulated in ankylosing spondylitis and associated with disease activity, hospitalization time and disease duration. Exp Ther Med 17:291\u2013297. https:\/\/doi.org\/10.3892\/etm.2018.6921","journal-title":"Exp Ther Med"},{"key":"3681_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/annrheumdis-2013-203419","volume":"73","author":"JS Smolen","year":"2014","unstructured":"Smolen JS, Braun J, Dougados M, Emery P, Fitzgerald O, Helliwell P, Kavanaugh A, Kvien TK, Landewe R, Luger T, Mease P, Olivieri I, Reveille J, Ritchlin C, Rudwaleit M, Schoels M, Sieper J, Wit M, Baraliakos X, Betteridge N, Burgos-Vargas R, Collantes-Estevez E, Deodhar A, Elewaut D, Gossec L, Jongkees M, Maccarone M, Redlich K, van den Bosch F, Wei JC, Winthrop K, van der Heijde D (2014) Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis 73:6\u201316. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203419","journal-title":"Ann Rheum Dis"},{"key":"3681_CR22","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(11)60071-8","volume":"377","author":"M Dougados","year":"2011","unstructured":"Dougados M, Baeten D (2011) Spondyloarthritis. Lancet 377:2127\u20132137. https:\/\/doi.org\/10.1016\/S0140-6736(11)60071-8","journal-title":"Lancet"},{"key":"3681_CR23","doi-asserted-by":"publisher","first-page":"5468","DOI":"10.1002\/14651858.CD005468.pub2","volume":"4","author":"LJ Maxwell","year":"2015","unstructured":"Maxwell LJ, Zochling J, Boonen A, Singh JA, Veras MM, Tanjong Ghogomu E, Benkhalti Jandu M, Tugwell P, Wells GA (2015) TNF-alpha inhibitors for ankylosing spondylitis. Cochrane Database Syst Rev 4:CD005468. https:\/\/doi.org\/10.1002\/14651858.CD005468.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"3681_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/annrheumdis-2017-211544","volume":"77","author":"Molnar C, Scherer A, Baraliakos X, de Hooge M, Micheroli R, Exer P, Kissling RO, Tamborrini G, Wildi LM, Nissen MJ, Zufferey P, Bernhard J, Weber U, Landewe RBM, van der Heijde D, Ciurea A, Rheumatologists of the Swiss Clinical Quality Management P","year":"2018","unstructured":"Molnar C, Scherer A, Baraliakos X, de Hooge M, Micheroli R, Exer P, Kissling RO, Tamborrini G, Wildi LM, Nissen MJ, Zufferey P, Bernhard J, Weber U, Landewe RBM, van der Heijde D, Ciurea A, Rheumatologists of the Swiss Clinical Quality Management P (2018) TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort. Ann Rheum Dis 77:63\u201369. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211544","journal-title":"Ann Rheum Dis"},{"key":"3681_CR25","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","volume":"373","author":"Baeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P, Deodhar A, Porter B, Martin R, Andersson M, Mpofu S, Richards HB, Group MS, Group MS","year":"2015","unstructured":"Baeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P, Deodhar A, Porter B, Martin R, Andersson M, Mpofu S, Richards HB, Group MS, Group MS (2015) Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis. N Engl J Med 373:2534\u20132548. https:\/\/doi.org\/10.1056\/NEJMoa1505066","journal-title":"N Engl J Med"},{"key":"3681_CR26","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3892\/ijmm.2018.4038","volume":"43","author":"Z Xu","year":"2019","unstructured":"Xu Z, Zhou X, Li H, Chen Q, Chen G (2019) Identification of the key genes and long noncoding RNAs in ankylosing spondylitis using RNA sequencing. Int J Mol Med 43:1179\u20131192. https:\/\/doi.org\/10.3892\/ijmm.2018.4038","journal-title":"Int J Mol Med"},{"key":"3681_CR27","doi-asserted-by":"publisher","first-page":"12481","DOI":"10.1073\/pnas.0605298103","volume":"103","author":"KD Taganov","year":"2006","unstructured":"Taganov KD, Boldin MP, Chang KJ, Baltimore D (2006) NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 103:12481\u201312486. https:\/\/doi.org\/10.1073\/pnas.0605298103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3681_CR28","doi-asserted-by":"publisher","first-page":"7212","DOI":"10.1038\/s41598-019-43691-9","volume":"9","author":"A Bitar","year":"2019","unstructured":"Bitar A, Aung KM, Wai SN, Hammarstrom ML (2019) Vibrio cholerae derived outer membrane vesicles modulate the inflammatory response of human intestinal epithelial cells by inducing microRNA-146a. Sci Rep 9:7212. https:\/\/doi.org\/10.1038\/s41598-019-43691-9","journal-title":"Sci Rep"},{"key":"3681_CR29","doi-asserted-by":"publisher","first-page":"e0122055","DOI":"10.1371\/journal.pone.0122055","volume":"10","author":"HY Xu","year":"2015","unstructured":"Xu HY, Wang ZY, Chen JF, Wang TY, Wang LL, Tang LL, Lin XY, Zhang CW, Chen BC (2015) Association between ankylosing spondylitis and the miR-146a and miR-499 polymorphisms. PLoS ONE ONE 10:e0122055. https:\/\/doi.org\/10.1371\/journal.pone.0122055","journal-title":"PLoS ONE ONE"},{"issue":"9","key":"3681_CR30","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/BRS.0000000000001339","volume":"41","author":"Bang-ping Qian","year":"2016","unstructured":"Qian BP, Ji ML, Qiu Y, Wang B, Yu Y, Shi W, Luo YF (2016) Identification of serum miR-146a and miR-155 as novel noninvasive complementary biomarkers for ankylosing spondylitis. Spine (Phila Pa 1976) 41:735\u2013742. https:\/\/doi.org\/10.1097\/BRS.0000000000001339","journal-title":"SPINE"},{"key":"3681_CR31","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.biopha.2017.11.067","volume":"97","author":"G Di","year":"2018","unstructured":"Di G, Kong L, Zhao Q, Ding T (2018) MicroRNA-146a knockdown suppresses the progression of ankylosing spondylitis by targeting dickkopf 1. Biomed Pharmacother 97:1243\u20131249. https:\/\/doi.org\/10.1016\/j.biopha.2017.11.067","journal-title":"Biomed Pharmacother"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-019-03681-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-019-03681-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-019-03681-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,30]],"date-time":"2020-12-30T19:22:04Z","timestamp":1609356124000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-019-03681-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,1]]},"references-count":31,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["3681"],"URL":"https:\/\/doi.org\/10.1007\/s11010-019-03681-x","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,1]]},"assertion":[{"value":"11 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"All authors have read the Journal\u2019s position on issues involved in ethical publication, and all authors have approved the final version of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}